Clarius Group LLC raised its stake in shares of Karuna Therapeutics, Inc. (NASDAQ:KRTX – Get Rating) by 8.4% during the 1st quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 119,696 shares of the company’s stock after buying an additional 9,283 […]